| 名稱(chēng) | CCDC6-RET WT/BaF3 |
| 型號(hào) | CBP73214 |
| 報(bào)價(jià) |  |
| 特點(diǎn) | CCDC6-RET WT/BaF3,母細(xì)胞：BaF3 |
產(chǎn)品搜索
產(chǎn)品分類(lèi)
相關(guān)文章
- TLR激動(dòng)劑藥物細(xì)胞篩選模型
- 核酸診斷新型冠狀病毒——假病毒標(biāo)準(zhǔn)品
- MTHFR基因多態(tài)性用藥指導(dǎo)標(biāo)準(zhǔn)品
- 購(gòu)買(mǎi)細(xì)胞株前需要了解的相關(guān)技術(shù)知識(shí)
- CNV參考品
- Cell Metab：雙信號(hào)通路失調(diào)協(xié)同促進(jìn)肺癌形成
- FGFR3-TACC3融合藥物細(xì)胞篩選模型
- ATCC細(xì)胞株的特殊性質(zhì)或標(biāo)志必須在整個(gè)培養(yǎng)期間始終存在
- MYC診斷標(biāo)準(zhǔn)品
- TSLP靶點(diǎn)藥物細(xì)胞篩選模型
聯(lián)系我們
聯(lián)系人：蔣經(jīng)理
電話(huà)：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
電話(huà)：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > kinase激酶細(xì)胞株 > CBP73214CCDC6-RET WT/BaF3
- 詳細(xì)內(nèi)容
| CBP73214 | |
| I. Introduction | |
Cell Line Name： | CCDC6-RET WT/BaF3 |
Host Cell: | BA/F3 |
| Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Application: | Anti-proliferation assay and PD assay |
Freeze Medium: | 90% FBS+10% DMSO |
Complete Culture Medium: | RPMI-1640+10%FBS+1ug/ml puromycin |
Mycoplasma Status: | Negative |
| II.Background | |
CCDC6, coiled-coil domain containing 6, has been shown to play a role in the DNA damaging signaling pathway acting as a substrate of ATM (PMID: 17420723). CCDC6 fusions with RET (PMID: 23154560, PMID: 26078337) and BRAF (PMID: 26314551) have been observed in multiple cancer types. | |
| III. Representative Data | |
1. WB of CCDC6-RET WT/BaF3WT
| |
2. Sanger of CCDC6-RET WT/BaF3
Figure 2. Breakpoint of CCDC6-RET WT/BaF3 | |
2. Anti-proliferation assay | |
Figure 3. CTG assay of for CCDC6-RET WT/BaF3 Stable Cell Line,the Gi50 was 137.3nM. | |
會(huì)員_a.png)